// App-Quantinova.ai

1243M-03 : HOSPITALIZATIONS, RECURRENT VENOUS THROMBOEMBOLISM OR VENOUS THROMBOEMBOLISM-RELATED DEATH, AND MAJOR BLEEDING, BY INDEX EVENT FROM THE AMPLIFY TRIAL

Researchers

Presenter

  • Theodore Leea

Principal Investigators

  • Cristina Masseriaa

  • Andrei Breaznaa

  • Gregory DiRussoa

  • Melissa Hamiltona

  • Ruslan Horblyuka

  • Jack Mardekiana

  • Anthony Porcaria

  • Alexander Cohena

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • Pfizer Inc.

  • Bristol-Myers Squibb

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Venous thrombosis

  • Deep vein thrombosis

  • Pulmonary embolism

Biomarkers

  • N/A

Drug/Treatment

  • Enoxaparin

  • Enoxaparin sodium

  • apixaban

  • Warfarin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved